资讯
车仆主导的《车用芳香剂》团体标准正式实施，引领车载香薰行业规范发展
近期，中国标准化协会委托车仆牵头，联合国内12家领先的生产、销售及检验单位共同制定的《车用芳香剂》团体标准（标准号：T/CAS 1202）正式发布实施。该标准的落地，填补了国内车用芳香剂行业无统一技术标准的空白，......
TMC Subsidiaries Submit Massive Deep-Sea Dataset to Public Database
As part of their regulatory obligations, TMC subsidiaries NORI and TOML have submitted extensive datasets to the International Seabed Authority's DeepData, covering a decade of exploration in the Cl......
Cority Wins Two E+E Leader Awards for AI Compliance and Emissions Innovation
Compliance Permit Analysis Agent and Next-Gen Emissions Calculation Management Toolset help enterprises reduce risk, improve auditability, and act faster on complex environmental requirements
TORONTO......
ALL ACCOR ANNOUNCES THE RETURN OF THE “DREAM TOURNAMENT”
Press release
April 16th, 2026
ALL ACCOR ANNOUNCES THE RETURN OF THE
“DREAM TOURNAMENT”
A UNIQUE OPPORTUNITY TO EXPERIENCE A DAY
IN THE SHOES OF A PARIS SAINT-GERMAIN PLAYER
ALL Accor, ......
Wellcome Leap Announces $2 Million Prize in $50 Million Quantum for Bio Challenge Program
First-ever demonstration of an end-to-end quantum-classical workflow for simulating complex therapeutics, unlocking a credible path to near-term quantum advantage in health
SAN DIEGO, April 16, 2026 ......
BitMEX Launches the 24/7 TradFi Campaign Featuring a 50,000 USDT Prize Pool
VICTORIA, Seychelles, April 16, 2026 (GLOBE NEWSWIRE) -- BitMEX, one of the safest crypto exchanges, announced today the launch of the TradFi Trade and Earn Campaign for users who trade its TradF......
中国与土耳其经贸合作再上新台阶，安卡拉唐人街项目正式启动建设
【本报安卡拉电】旨在进一步深化中国与土耳其经贸合作、推动“一带一路”框架下务实发展的安卡拉唐人街（China Town Ankara）项目，近日正式进入建设阶段。
该项目作为土耳其首个专门面向中国品牌打造的主题商业与贸......
国泰君安国际荣获2025年度离岸中资基金大奖“货币市场基金 - 港币(1年)”冠军
近日，香港中资基金业协会（HKCAMA）与彭博联合宣布2025年度“离岸中资基金大奖”获奖名单。国泰海通集团下属公司国泰君安国际控股有限公司（“国泰君安国际”或“公司”，股份代号：1788.HK）旗下国泰君安港元货币市......
Optomec 为培养下一代工程师重磅推出气溶胶喷射系列教育机
全球领先的增材制造硬件与软件提供商Optomec今日宣布推出气溶胶系列教育机。这是一套一站式的学习解决方案，旨在为大学高校和职业技术学院带来实践型的印刷电子与先进3D制造方面的培训。
该平台基于Optomec的专利气......
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced N
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine
This press release is not intended for US or......
